Mission Therapeutics Successfully Completes First Clinical Assessment for Lead DUB Program, MTX652
The successful delivery of another Phase I clinical trial by the team at Simbec-Orion has resulted in the achievement of ...Read more >
News
Patient recruitment strategies for rare disease trials
One of the key challenges facing researchers working on treatments for rare diseases is recruitment for clinical trials. Because these ...Read more >
The 4 Types of clinical trial monitoring
In recent decades, clinical trials and their methodologies have evolved significantly. New technologies have led to improved research methods, techniques ...Read more >
Advantages and Disadvantages of Clinical Outsourcing
Pharmaceutical companies all over the world outsource some or all elements of their clinical trials in order to better manage ...Read more >
Considerations in rare disease study design
Designing a clinical trial is a complex and challenging process. There are several key factors that researchers have to consider, ...Read more >
Sustained clinical response in a patient with metastatic breast cancer treated with MP0274
Today we celebrate the success of our colleague, and Scientific Advisory Board member, Dr Samson Fung. Dr Fung was recently ...Read more >
What is Research and Development in the Pharmaceutical Sector?
Pharmaceutical R&D is the process of developing drugs and pharmaceuticals so they are appropriate and safe for market use. The ...Read more >
Clinical Trial Data Management: Explained
Clinical data management (CDM) is one of the most integral processes in any clinical study. Data is at the heart ...Read more >
Simbec-Orion supports AL-S Pharma with Phase II ALS Study
Amyotrophic lateral sclerosis (ALS) is a rare, progressive neurodegenerative disease that affects the motor neurons controlling voluntary muscle movement. The ...Read more >
Welsh STEM Award Nominations for Two Simbec-Orion Scientists
We are thrilled that two of our Simbec-Orion colleagues are amongst the Welsh businesses and individuals shortlisted in the Wales ...Read more >
Oxford Cannabinoid appoints Simbec-Orion to run first clinical trial on lead compound
Simbec-Orion is honoured to have been trusted by Oxford Cannabinoid Technologies to conduct this milestone first-in-human, Phase1 clinical trial of its ...Read more >
Writing a protocol for clinical research
A clinical research protocol is one of the most vital components of any study. It describes an overview of the ...Read more >